M. C. Keefer

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

John R. Mascola, S W Snyder, O. S. Weislow et al. · The Journal of Infectious Diseases · 1996 · 434 citations

Life Sciences, Immunology, Microbiology +10

Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults

Bria Graham, Thomas J. Matthews, Robert B. Belshe et al. · The Journal of Infectious Diseases · 1993 · 156 citations

Life Sciences, Immunology, Infectious Diseases +15

Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical Trial

Bria Graham, Robert B. Belshe, M L Clements et al. · The Journal of Infectious Diseases · 1992 · 132 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with >=400 CD4 Lymphocytes: Implications for Applying Measurements to Individual Patients

William B. Paxton, Robert W. Coombs, M. Juliana McElrath et al. · The Journal of Infectious Diseases · 1997 · 89 citations · Full text

Life Sciences, Biostatistics, Infectious Diseases +17

Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group

M. C. Keefer, Mark Wolff, Geoffrey J. Gorse et al. · AIDS Research and Human Retroviruses · 1997 · 82 citations

Veterinary Medicine, Immunology, Infectious Diseases +17